Open Monoclonal Technology Inc.
Division of Ligand Pharmaceuticals Inc.
www.omtinc.net
Latest From Open Monoclonal Technology Inc.
WuXi Eyes Growing Biologics Business With New Integrated Center
An integrated biologics solution center is China's largest CRO WuXi AppTec's first investment completes its going private move. Aiming to provide full range of services to clients developing antibody drugs, WuXi plans more investment within the next 12 months.
Deals Shaping The Medical Industry, January 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2015.
Deals Shaping The Medical Industry, December 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.
Deals Shaping The Medical Industry, July 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2015.
Company Information
- Industry
-
Biotechnology
- Drug Discovery Tools
-
Large Molecule
- Antibodies
- Transgenics
- Pharmaceuticals
- Therapeutic Areas
- Non-Specific
- Alias(es)
- OMT Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Ligand Pharmaceuticals Inc.
- Senior Management
-
Roland Buelow, PhD, CEO
Sandra Cavanah Tucher, CFO
Marianne Brüggemann, PhD, Dir., Research
Brian Lundstrom, CBO - Contact Info
-
Open Monoclonal Technology Inc.
Phone: (650) 799-1090
Palo Alto, CA 94303
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice